Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 67877-444

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 67877-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dalfampridine 10mg 60tab

Each tablet contains 10mg of Dalfampridine and should only be taken whole. Tablets should be stored at controlled room temperature and dispensed in containers with child-resistant closures. A medication guide should be dispensed to each patient. Keep out of reach of children. Manufactured by Iatrica Pharmaceuticals in India and distributed by Ascend Laboratories, LLC. Dosage information is available in the package insert.*

FDA Label Image

Dalfampridine-equa (Dalfampridine Equa)

This appears to be a formula used in healthcare to calculate a patient's creatinine clearance (CrCl) based on their age, weight, and serum creatinine levels. However, without additional information such as the patient's gender or medical condition, it is not possible to determine the context or significance of this calculation.*

FDA Label Image

Dalfampridine-figure1 (Dalfampridine Figure1)

The given text contains some characters that are not recognizable as English. The text is either corrupt or not in English language. Hence, the description cannot be generated.*

FDA Label Image

Dalfampridine-figure2 (Dalfampridine Figure2)

This appears to be a chart representing data on patient results of a medical study on the effects of a 10mg b.id medication (Dalfampridine Extended-release Tablets) in comparison to a placebo, with results shown as percentages of patients. The chart provides the average percent increase in walking speed from baseline for each treatment (placebo and medication) at various thresholds. P-values are also provided to compare the effects of the medication to the placebo at each threshold.*

FDA Label Image

Dalfampridine-struc (Dalfampridine Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.